US Postoperative Pain Management Market to Reach US$19.608 Billion by 2033, Growing at a CAGR of 5.4%, Led by North America's 38% Market Share | Top Companies - Pacira Pharmaceuticals, Heron Therapeutics, Johnson & Johnson, Mallinckrodt, Vertex Pharmaceut

Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM Intelligence research analysis, the global postoperative pain management market was valued at US$ 39.26 billion in 2023 and increased to US$ 41.17 billion in 2024. The market is projected to reach US$ 65.36 billion by 2033, expanding at a CAGR of 5.4% during the forecast period 2025-2033.

Growth is driven by rising surgical procedures worldwide and an aging population requiring advanced pain control solutions. Ongoing innovations, including Pacira's EXPAREL and Heron's ZYNRELEF, are supporting the transition toward long-acting, non-opioid, and multimodal analgesic approaches. Increasing regulatory scrutiny and clinical efforts to reduce opioid dependence are further accelerating adoption of safer, effective postoperative pain management therapies.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/postoperative-pain-management-market?praveen

United States: Recent Industry Developments
✅ In December 2025, U.S. healthcare providers expanded adoption of opioid-sparing postoperative pain management programs, integrating nerve blocks, NSAIDs, and digital pain monitoring to address opioid misuse concerns.

✅ In November 2025, medical technology companies launched AI-enabled pain assessment platforms that analyze patient-reported outcomes and vital data to personalize postoperative analgesia.

✅ In October 2025, U.S. hospitals increased investment in regional anesthesia techniques, including ultrasound-guided nerve blocks, to improve pain control and accelerate patient mobility after surgery.

✅ In September 2025, partnerships between pharmaceutical firms and healthcare systems supported the development of next-generation analgesics, focusing on reduced side effects and improved postoperative recovery.

Japan: Recent Industry Developments
✅ In December 2025, Japanese hospitals expanded the use of multimodal postoperative pain management protocols, combining non-opioid analgesics, regional anesthesia, and digital pain assessment tools to improve recovery outcomes and reduce opioid reliance.

✅ In November 2025, pharmaceutical companies in Japan introduced long-acting local anesthetics and non-opioid pain relief formulations, supporting safer and more sustained postoperative pain control.

✅ In October 2025, collaborations between academic hospitals and medical device firms advanced patient-controlled analgesia (PCA) systems with smart monitoring, enhancing precision dosing and patient safety after surgery.

✅ In September 2025, Japan's healthcare regulators promoted Enhanced Recovery After Surgery (ERAS) guidelines, encouraging standardized postoperative pain management practices across surgical specialties.

Postoperative Pain Management Market: Drivers
- The market is growing due to increasing volumes of surgical procedures and rising focus on improving patient recovery outcomes. Growing adoption of multimodal pain management approaches, including opioids, non-opioid analgesics, and regional anesthesia, is driving demand. Advancements in drug formulations, delivery systems, and nerve block techniques improve efficacy and safety. Expanding hospital infrastructure, enhanced recovery protocols, and focus on reducing hospital stay and complications support sustained market growth.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/postoperative-pain-management-market?praveen

Postoperative Pain Management Market : Major Players
Pacira Pharmaceuticals, Heron Therapeutics, Mallinckrodt, Johnson & Johnson, Vertex Pharmaceuticals, Virpax, Grünenthal, and Oakwood Labs.

Market Segmentation Analysis - Postoperative Pain Management
By Drug Type
Opioids dominate with approximately 45% share, driven by their strong analgesic efficacy in managing moderate to severe postoperative pain. Non-steroidal anti-inflammatory drugs (NSAIDs) account for around 30%, favored for multimodal pain management strategies and reduced opioid dependency. Local anesthetics hold nearly 15%, widely used in regional blocks and wound infiltration techniques. Other drug types represent about 10%, including acetaminophen, adjuvant analgesics, and emerging non-opioid therapies.

By Route of Administration
Injectable administration leads with nearly 50% share, reflecting widespread use of intravenous and intramuscular delivery for rapid pain control immediately after surgery. Oral administration accounts for around 35%, commonly used during recovery and discharge phases for ongoing pain management. Regional and topical routes hold approximately 10%, including epidural, nerve block, and transdermal approaches. Other routes represent roughly 5%, encompassing intranasal and patient-controlled analgesia systems.

By Distribution Channel
Hospital pharmacies dominate with about 65% share, driven by high surgical volumes and the need for controlled dispensing of pain medications. Retail pharmacies account for around 25%, supporting post-discharge pain management prescriptions. Online and specialty pharmacies represent approximately 10%, gaining traction for follow-up medications and patient convenience.

Regional Analysis - Postoperative Pain Management Market
North America - 38% Share
North America leads with 38% share, driven by high surgical volumes, advanced hospital infrastructure, strong adoption of multimodal pain management strategies, and widespread use of both pharmacological and device-based pain control solutions in the U.S. and Canada.

Europe - 28% Share
Europe holds 28% share, supported by increasing focus on patient-centric care, enhanced recovery after surgery (ERAS) protocols, and strong adoption of non-opioid and regional anesthesia techniques across Germany, the U.K., France, and Italy.

Asia-Pacific - 22% Share
Asia-Pacific accounts for 22% share, fueled by rising number of surgical procedures, improving healthcare infrastructure, growing awareness of effective pain management, and expanding access to advanced therapies in China, India, Japan, and South Korea.

South America - 7% Share
South America represents 7% share, driven by improving surgical care standards, increasing hospital investments, and growing adoption of modern pain management approaches in Brazil, Argentina, and Chile.

Middle East & Africa - 5% Share
Middle East & Africa account for 5% share, supported by healthcare infrastructure development, rising surgical volumes, and gradual adoption of advanced postoperative pain management solutions in the UAE, Saudi Arabia, and South Africa.

Purchase this Report :
https://www.datamintelligence.com/buy-now-page?report=postoperative-pain-management-market?praveen

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?praveen

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.